Novozymes Receivables 2011-2023 | NVZMY

Novozymes receivables for the quarter ending December 31, 2023 were $0.621B, a 5.27% increase year-over-year.

  • Novozymes receivables for 2023 were $0.621B, a 5.27% increase from 2022.
  • Novozymes receivables for 2022 were $0.59B, a 1.21% decline from 2021.
  • Novozymes receivables for 2021 were $0.597B, a 21% increase from 2020.

Novozymes Receivables 2011-2023 | NVZMY

  • Novozymes receivables for 2023 were $0.621B, a 5.27% increase from 2022.
  • Novozymes receivables for 2022 were $0.59B, a 1.21% decline from 2021.
  • Novozymes receivables for 2021 were $0.597B, a 21% increase from 2020.
Related Stocks
Company NameMarket
Cap
Linde (LIN)$218.8B
Sherwin-Williams (SHW)$97.4B
Ecolab (ECL)$70.8B
PPG Industries (PPG)$29.1B
International Flavors & Fragrances (IFF)$23.6B
Celanese (CE)$9.3B
Axalta Coating Systems (AXTA)$8.7B
CSW Industrials (CSWI)$7.1B
Element Solutions (ESI)$6.9B
Balchem (BCPC)$5.8B
Arcadium Lithium (ALTM)$5.8B
Valvoline (VVV)$5.5B
NewMarket (NEU)$5.3B
Nissan Chemical (NNCHY)$5.1B
H B Fuller (FUL)$4.2B
Ashland (ASH)$4B
Sensient Technologies (SXT)$3.4B
Quaker Houghton (KWR)$3B
Minerals Technologies (MTX)$2.6B
Hawkins (HWKN)$2.6B
Perimeter Solutions, SA (PRM)$2B
Orbia Advance, S.A.B De C.V (MXCHY)$1.8B
Ingevity (NGVT)$1.6B
DAQO New Energy (DQ)$1.4B
ELEMENTIS (ELMTY)$1.3B
Huabao Holdings (HUIHY)$943M
Orion S.A (OEC)$914M
AdvanSix (ASIX)$829M
Westlake Chemical Partners LP (WLKP)$797M
Green Plains (GPRE)$735M